Protection against Omicron by Mucosal IgA Antibodies In this study, SARS-CoV-2 infection
before vaccination was found to elicit mucosal IgA, which protects against infection …

Mucosal immunity has a pivotal role in protection from respiratory viral infections. 1 The
current authors have showed substantial protection from omicron infection by high …

Response to BA. 2.86 Infection after Vaccination Infection with the BA. 2.86 subvariant in a
vaccinated and previously infected person yielded a strong induction of mucosal IgA binding …

Background Recent reports demonstrate robust serological responses to a single dose of
messenger RNA (mRNA) vaccines in individuals previously infected with SARS-CoV-2. Data …

2 Kimura I, Kosugi Y, Wu J, et al. The SARS-CoV-2 lambda variant exhibits enhanced infectivity
and immune resistance. Cell Rep 2022; 38: 110218. 3 Bruel T, Hadjadj J, Maes P, et al. …

Vaccination offers protection against severe COVID-19 caused by SARS-CoV-2 omicron but
is less effective against infection. Characteristics such as serum antibody titer correlation to …

Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal
characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 …

Background Emerging data support detectable immune responses for months after severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is …

Objective To determine the long‐term impact of prior SARS‐CoV‐2 infection on immune
responses after COVID‐19 vaccination. Methods Using longitudinally collected blood samples …

We previously highlighted the importance of mucosal IgA, but not IgG, in preventing SARS-CoV-2
infection. 1 Although intramuscular SARS-CoV-2 vaccines might strengthen mucosal …